Skip to main content

Clinical Research

At the UCI Chao Family Comprehensive Cancer Center (CFCCC) — Orange County's only National Cancer Institute-designated comprehensive cancer center — patients receive compassionate and highly personalized treatment. The cancer center also provides patients with access to clinical trials and cutting-edge treatments as they are developed. At any given time, UCI is participating in at least 200 clinical trials, many of them developed by CFCCC members. For more information, please contact us at ucstudy@hs.uci.edu or 877-827-8839.

Find a UCI Clinical Trial

Search from a comprehensive list of active trials that are currently open to recruitment conducted by investigators at CFCCC. If there is a clinical trial that you are interested in learning more about, please contact the Stern Center at ucstudy@hs.uci.edu  or 877-827-8839.

Click Here

Disease-Based Trial Flowcharts

The flowcharts are designed to help you and your provider identify CFCCC clinical trials that are associated with specific types of cancer. If there is a clinical trial that you are interested in learning more about, please contact the Stern Center at ucstudy@hs.uci.edu or 877-827-8839.

Click Here

science presentation

Disease-Oriented Teams

Disease-Oriented Teams are multidisciplinary groups of basic, translational, clinical, and population health investigators who collaborate on a specific cancer area in order to further the translation of CFCCC discoveries through the pipeline towards interventional clinical trials. As the first component of the CFCCC’s two-step clinical research review process, the focus of the DOTs is to ensure rigorous internal scientific review of protocols, curate the clinical trial portfolio, and drive innovation.

molecule presentation

Protocol Review and Monitoring Committee

The CFCCC’s Protocol Review and Monitoring Committee (PRMC) is the second step in the review process for new cancer-related clinical research studies. The PRMC evaluates new studies for scientific merit, feasibility, overall portfolio balance, and potential to accrue populations that are underrepresented in clinical trials. The PRMC also monitors the progress and continued relevance of studies that are open to enrollment.

NCI Early Therapeutics Clinical Trials Network (ETCTN): Clinical Trials List

This is a list of NCI clinical trials that are available to the UCI Chao Family Comprehensive Cancer Center.

Click Here


 

Cancer Therapy Evaluation Program (CTEP): List of Agents

This is the list of agents available under CTEP Collaborative Agreements for Clinical and Non-Clinical Studies.

Click Here


 

Fall 2020 Newsletter

Highlighting CFCCC's basic, clinical and translational research.

Click Here
Spring 2020 Newsletter

Highlighting CFCCC's basic, clinical and translational research.

Click Here
Spring 2019 Newsletter

Highlighting lung cancer research and clinical trials.

Click Here
Fall 2018 Newsletter

Highlighting gynecologic cancer research and clinical trials.

Click Here
Spring 2018 Newsletter

Highlighting GI cancer research and clinical trials.

Click Here
Fall 2017 Newsletter

Highlighting breast cancer research and clinical trials.

Click Here
Winter 2017 Newsletter

Highlighting hematology oncology research and clinical trials.

Click Here